# Croda International reports Q3 sales growth and maintains FY24 profit outlook

- Link: https://www.directorstalkinterviews.com/croda-international-reports-q3-sales-growth-and-maintains-fy24-profit-outlook/4121176640
- Published: 2024-11-11T07:49:09+00:00
- Author: Amilia Stone

**[Croda International Plc](https://www.directorstalkinterviews.com/ftse-company/croda-international/crdo.l)**(
LON:CRDA) has provided an update on its sales performance in the third quarter of
2024 (the three months ended 30 September 2024).

·      Group sales of £407m, up 5% versus the prior year and up 8% at constant currency

·      FY24 outlook unchanged: adjusted profit before tax (PBT) range of £260m-£
280m at constant currency

·      Adverse impact of currency translation on FY24 PBT expected to be approximately
£14m 

·      Refinanced Revolving Credit Facility with a new 5-year £630m facility

**Group performance**

|  |  | **Change versus prior year** | 
|  | Q324£m | Q323£m | Change | Constant currency change | 
| Consumer Care | **228** | 218 | 5% | 7% | 
| Life Sciences | **129** | 125 | 3% | 6% | 
| Industrial Specialties | **50** | 44 | 14% | 16% | 
| Group | **407** | **387** | **5%** | **8%** |

Third quarter 2024 sales increased to £407m, up 5% on a reported basis on the prior
year and up 8% in constant currency.  Overall Group results were in line with expectations
benefitting from more stable volume demand in key markets and continuing cost control
actions.  

As previously disclosed, for full year 2024 we still expect Group adjusted profit
before tax to be between £260m and £280m at constant currency. Sterling strengthened
further in the third quarter, and we estimate the adverse impact of currency translation
on full year Group adjusted profit before tax to be approximately £14m assuming 
30 September 2024 exchange rates for the remainder of the year.

Effective 25 October 2024, we successfully refinanced our bank Revolving Credit 
Facility with a new 5-year £630m multi-currency facility.

**Consumer Care**

Reported sales in Consumer Care were up 5% versus the prior year whilst constant
currency sales grew by 7%, driven by higher sales volumes as demand stabilised and
ongoing customer regains were realised. 

Consumer Care sales in the quarter were in line with our expectations. We saw ongoing
momentum in Fragrances & Flavours and Home Care, as well as good demand from local
customers in Beauty, but lower demand from multi-national Beauty customers compared
to the previous quarter.

**Life Sciences**

Reported sales in Life Sciences were up 3% versus the prior year whilst constant
currency sales grew by 6%.

Sales were higher in both Crop Protection and Seed Enhancement, with increased sales
volumes benefitting from more stable customer inventories and demand.

In Pharma, the lipids business continues to grow as customer pipelines for next 
generation drugs continue to expand, however sales for consumer health applications
are yet to see a recovery.

**Industrial Specialties**

Reported sales in Industrial Specialties grew by 14% versus the prior year whilst
constant currency sales grew by 16% driven by higher sales volumes.

> **Steve Foots, Croda International Chief Executive Officer, said:**
> _“Our third quarter sales performance reflects ongoing momentum in our Fragrances
> and Flavours business within Consumer Care and improved sales in our agriculture
> businesses in Life Sciences. Whilst we are benefitting from more stable customer
> inventories and demand in key markets and geographies, the overall trading environment
> remains challenging. We continue to focus on strengthening the Group through delivering
> our strategy combined with tight cost control and capital discipline.” _

**Currency translation**

Constant currency expectations are based on the Group’s average exchange rates through
2023 which were US$1.243 and €1.149. The US Dollar and the Euro represent approximately
65% of the Group’s currency translation exposure. We estimate that the average annual
currency translation impact on adjusted operating profit is £1m per Dollar cent 
movement per annum and £1m per Euro cent movement per annum.

Croda International will report financial results for full year 2024 on 25 February
2025. 

Share on:
